Segle is a Spanish biotechnological cosmetics brand founded in Barcelona that formulates dermocosmetic serums and creams using 'green' (plant-derived, e.g. spirulina, apple and argan stem cells) and 'blue' (marine-derived) biotechnology actives to treat wrinkles, blemishes and loss of luminosity. It sells premium products through pharmacies, aesthetic clinics and its own e-commerce rather than mass retail, and has expanded internationally with Mexico as its fastest-growing market (reported +48% sales in 2025 and a €1.5M investment earmarked for Mexican expansion). The company rebranded from 'Segle Clinical' to 'Segle Biotech Skincare'.
SectorsBiotech Cosmetics, Skincare, Dermocosmetics, Consumer Brand, E-commerce
Start-up MapConsumer › D2C beauty & wellness brands
Founders
A
Alfonso Fuertes Ollé
Co-Founder
M
Mónica Lizondo Carbó
Co-Founder & CEO
Global models 3
GGlossier
United States · www.glossier.com ↗
A venture-backed premium skincare brand that sells through its own e-commerce and selected retail partners rather than mass-market retail.
$266MComparable
FFunction of Beauty
United States · www.functionofbeauty.com ↗
A venture-backed premium brand that sells science-led personal care formulations, mainly through its own online channel.
~$150MComparable
AArcaea
United States · www.arcaea.com ↗
A Ginkgo Bioworks spin-out building a beauty business around biotech-made active ingredients, the same biotech-actives idea Segle sells on.
$78MComparable
In the same niche 14 others
See all in the Start-ups Map →
FFreshly Cosmetics
Reus
Series A · €18.9M
CCocunat
Barcelona
No stage disclosed · €9.4M
TTrending Corporate
Bollullos de la Mitación
No stage disclosed · €6.5M
K
Kriim
Barcelona
Seed (estimated) · €2.5M
SSaigu Cosmetics
Valencia
Series A (estimated) · €1.9M
LLICO Cosmetics
Sevilla
Seed · €1M
Notes: Most funded first
Investors 3
Open as list →Funding rounds 2
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2022-01-03 | No stage disclosed | — | Lead not disclosed |
| 2021-01 | Seed | — |
Lead not disclosed
+1 more
|
News
No coverage on record yet.


